Recombinant mussel mucin-regenerated silk fibroin composite gel and preparation method thereof
Through cross-linking and auxiliary material compounding technology, recombinant mussel mucin-regenerated silk fibroin complex microgel was prepared, which solved the shortcomings of recombinant mucin and regenerated silk fibroin in tissue filling and repair, and achieved high efficiency The tissue filling and repair effects provide an innovative biomedical material.
Patent Information
- Application Number
- CN202411078337.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-19
AI Technical Summary
The existing recombinant mussel mucin has a low molecular weight, a short metabolic cycle, and insufficient viscoelastic and supportive properties of aqueous solutions, so it cannot be used as tissue filling and repair materials; regenerated silk fibroin lacks the ability to promote cell adhesion, growth and differentiation in tissue regeneration. Specific peptide sequences limit their application in tissue engineering and regenerative medicine.
By cross-linking recombinant mussel mucin and regenerated silk fibroin, and compounding with auxiliary materials such as sodium hyaluronate, an injectable recombinant mucin-regenerated silk fibroin complex microgel was prepared, and combined with sieve pulverization. Technologically, soft tissue fillers with excellent biocompatibility and plasticity are formed.
Improve the anti-inflammatory, antioxidant, cell migration and differentiation functions of composite microgels, enhance its effect in tissue filling and repair, extend the maintenance time of fillers, and provide an innovative tissue engineering and Regenerative medical materials.
Smart Images

Figure CN118976156A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of tissue engineering, and in particular relates to a recombinant mussel mucin-regenerated silk fibroin composite microgel and a preparation method thereof. Background Art
[0002] With the rapid development of tissue engineering and regenerative medicine in recent years, the clinical application of injectable soft tissue filling materials has been continuously expanded, not only for cosmetic purposes, but also for minimally invasive treatment of clinical diseases such as chronic wound repair, osteoarthritis treatment, articular cartilage defect repair, tendon injury repair, myocardial injury repair, spinal cord injury repair and brain tissue injury repair. Mussel mucin is a natural polymer material found in mussel byssus, which has multiple functions such as anti-inflammatory, antibacterial, antioxidant, anti-allergic, and inhibiting pigment deposition. In particular, due to the strong adhesion, biocompatibility and the effect of promoting cell migration, proliferation and differentiation, mussel mucin has a wide range of application potential in the field of biomedical materials, including as a medical adhesive in surgery, promoting wound healing, and as a coating for drug-eluting stents. In terms of promoting wound healing, mussel mucin can form a moist healing environment, promote the adhesion and crawling of epithelial cells, and accelerate the healing of wounds or ulcers. At the same time, mussel mucin can also reduce the formation of wound scars by inhibiting excessive inflammatory reactions and preventing excessive proliferation of granulation tissue. Compared with naturally extracted mussel mucin, recombinant mussel mucin prepared by synthetic biology technology highly simulates the characteristics of natural mussel mucin. At the same time, recombinant technology can reduce costs, increase production, and avoid the limitation of raw materials and environmental pollution. However, mussel mucin prepared by recombinant technology usually has a low molecular weight (≤25000Da), a short metabolic cycle in the body, and the viscoelasticity and support of the recombinant mussel mucin aqueous solution are extremely low, which makes it impossible to use it as a tissue filling and repair material.
[0003] Regenerated silk fibroin is a natural polymer material that is favored for its excellent plasticity and excellent mechanical properties. It can be processed into a variety of structures such as film, sponge, gel or microparticle forms, which can effectively support and promote the growth and development of cells and tissues. Due to its unique biocompatibility and bioactivity, regenerated silk fibroin has broad application prospects in the fields of tissue engineering and regenerative medicine, and is expected to become a soft tissue filling material with important market value. Although regenerated silk fibroin contains 18 amino acids such as glycine, alanine, and serine, and exhibits a nanofibrillar secondary structure similar to collagen, its amino acid sequence lacks specific peptide sequences, which are essential for promoting cell adhesion, growth and differentiation. Therefore, in order to enhance the biological activity of regenerated silk fibroin and improve its ability in tissue regeneration, it is usually necessary to modify or modify its structure, or combine it with other biomaterials to improve the ability of regenerated silk fibroin to induce tissue regeneration.
[0004] Based on the characteristics of recombinant mussel mucin and regenerated silk fibroin materials, if innovative technology is used to compound the two and prepare a soft tissue filler that combines the specific functions of both materials, it will be a tissue engineering and regenerative medicine material with superior performance. Summary of the invention
[0005] In view of the shortcomings of the prior art, the present invention provides a recombinant mussel viscoelastic protein-regenerated silk fibroin composite microgel and a preparation method thereof.
[0006] The technical scheme of the present invention is as follows: a recombinant mussel mucin-regenerated silk fibroin composite gel, comprising recombinant mussel mucin, regenerated silk fibroin and auxiliary materials, wherein the mass ratio of the cross-linking of the recombinant mussel mucin and the regenerated silk fibroin is 1:1.5-11; the auxiliary materials are selected from sodium carboxymethyl cellulose, polyethylene glycol, hydroxypropyl cellulose or sodium hyaluronate.
[0007] Preferably, the recombinant mussel mucin-regenerated silk fibroin composite gel comprises recombinant mussel mucin, regenerated silk fibroin and sodium hyaluronate, wherein the mass ratio of the cross-linking of the recombinant mussel mucin and the regenerated silk fibroin is 42:83.
[0008] The present invention also provides a method for preparing the recombinant mussel viscoprotein-regenerated silk fibroin composite gel, comprising the following steps:
[0009] 1) Weigh recombinant mussel viscoprotein and regenerated silk fibroin, add to lithium bromide solution and stir to dissolve, then add BDDE and stir evenly, and let stand for cross-linking.
[0010] 2) The cross-linked gel was crushed into small pieces, and then the gel was washed with PBS solution to remove the catalyst and cross-linking agent remaining in the gel;
[0011] 3) Collect the washed gel by filtration, and pass the gel through a stainless steel mesh to obtain microgel.
[0012] 4) Weigh the microgel obtained in step 3, add the auxiliary material solution to the microgel, stir and compound, and after compounding, fill with a prefilled syringe and perform moist heat sterilization.
[0013] Preferably, in the step 1), the total amount of the recombinant mussel mucin and the regenerated silk fibroin is 5.95 times the amount of BDDE added.
[0014] Preferably, in step 1), the amount of lithium bromide solution added is 5 ml, and the concentration is 12M.
[0015] Preferably, in step 1), the cross-linking temperature is 28° C. and the cross-linking time is 48 h.
[0016] Preferably, in step 2), the washing condition is to use 150 ml of 10 mM PBS solution to wash the gel 10 times, each time for 30 minutes.
[0017] Preferably, in step 3), the condition for obtaining the microgel is to pass the gel through a 60-mesh stainless steel sieve three times to obtain the microgel.
[0018] Preferably, in step 4), the concentration of the excipient solution is 4-50 mg / mL.
[0019] Preferably, in step 4), the ratio of the auxiliary material solution to the microgel is 1:3 to 1:20.
[0020] Preferably, in step 4), the moist heat sterilization temperature is 121° C. and the sterilization time is 8 min.
[0021] The recombinant mussel mucin-regenerated silk fibroin composite gel provided by the present invention is used in soft tissue filling for facial plastic surgery, chronic wound repair, osteoarthritis treatment, articular cartilage defect repair, tendon injury repair, myocardial injury repair, spinal cord injury repair and brain tissue injury repair.
[0022] Beneficial effects of the present invention: According to the scheme of the embodiment of the present invention, a recombinant mussel mucin-regenerated silk protein composite microgel is prepared by cross-linking technology and combined with sieving and crushing. Further, the composite microgel is compounded with auxiliary materials such as sodium hyaluronate to prepare an injectable soft tissue regeneration filler. Recombinant mussel mucin simulates the characteristics of natural mussel foot silk protein and has multiple functions such as anti-inflammatory, antibacterial, antioxidant, anti-allergic, and inhibiting pigment deposition. Due to its strong adhesion, biocompatibility and the effect of promoting cell migration, proliferation and differentiation, it has a wide range of application potential in the field of biomedical materials, including as a medical adhesive in surgery, promoting wound healing, and as a coating for drug eluting stents. In terms of promoting wound healing, mussel mucin can form a moist healing environment, promote the adhesion and crawling of epithelial cells, and accelerate the healing of wounds or ulcers. At the same time, recombinant mussel mucin can also inhibit excessive inflammatory reactions and prevent excessive proliferation of granulation tissue, thereby reducing the formation of wound scars.
[0023] Regenerated silk fibroin is a natural biopolymer material with excellent biocompatibility and biodegradability. It is composed of 18 kinds of amino acids, many of which are essential for human cells. It has the effect of accelerating cell metabolism and delaying skin aging. Furthermore, regenerated silk fibroin has excellent plasticity and excellent mechanical properties. It can be processed into a variety of structures such as film, sponge, gel or microparticle form. These structures can effectively support and promote the growth and development of cells and tissues. Therefore, due to the unique biocompatibility and bioactivity of regenerated silk fibroin, it has broad application prospects in the fields of tissue engineering and regenerative medicine, and is expected to become a soft tissue filling material with important market value.
[0024] The recombinant mussel mucin-regenerated silk fibroin composite microgel prepared in the present invention has the functions of promoting the anti-oxidation, anti-inflammatory, adhesion, growth, proliferation and differentiation of endogenous tissue cells. In addition, the injectable soft tissue regeneration filler prepared by compounding the composite microgel with auxiliary materials such as sodium hyaluronate not only has the advantages of outstanding filling effect and good plasticity when used as a tissue engineering and regenerative medicine material, but also the composite microgel in the filler can induce the regeneration of fibroblasts and collagen in the tissue, prolonging the effect maintenance time of the filler, and is an innovative tissue engineering and regenerative medicine material. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 A schematic flow chart showing a method for preparing a recombinant mussel mucin-regenerated silk fibroin composite gel injectable soft tissue regeneration filler according to one embodiment of the present invention;
[0026] Figure 2 The infrared spectra of the composite gels prepared according to Examples 1 and 7 of the present invention are shown;
[0027] Figure 3 The microscopic image (a) and the particle size distribution diagram (b) of the composite microgel prepared according to Example 7 of the present invention are shown;
[0028] Figure 4 A scanning electron microscope image of the freeze-dried composite microgel prepared according to Example 7 of the present invention is shown;
[0029] Figure 5 Shown are pictures of recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration fillers prepared according to Example 1 (a) and Example 7 (b) of the present invention;
[0030] Figure 6 A graph showing the pushing force data of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention;
[0031] Figure 7 The antioxidant data of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Examples 1-7 of the present invention are shown;
[0032] Figure 8 The cytotoxicity data of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Examples 7-10 of the present invention are shown;
[0033] Fig. 9 The data showing the anti-inflammatory polarization of macrophages induced by the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention;
[0034] Fig.10 The anatomical picture of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention injected into the subcutaneous tissue of rats for 3 months is shown;
[0035] Fig.11 The H&E staining picture of tissue sections of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention injected into the subcutaneous tissue of rats for 3 months is shown;
[0036] Fig.12 The Masson staining picture of the tissue section of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention injected into the subcutaneous tissue of rats for 3 months is shown;
[0037] Fig.13The CD31 immunofluorescence staining picture of tissue sections of rats injected subcutaneously for 3 months with the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention is shown;
[0038] Fig.14 The CD90 immunofluorescence staining picture of the tissue section of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention injected into the subcutaneous tissue of rats for 3 months is shown;
[0039] Fig.15 The H&E staining pictures of the main organ tissue sections of rats injected subcutaneously for 3 months with the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler prepared according to Example 7 of the present invention are shown; DETAILED DESCRIPTION
[0040] The following embodiments can enable those skilled in the art to more fully understand the present invention, but the present invention is not limited to the scope of the embodiments.
[0041] Example 1
[0042] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0043] Weigh 1.25 g of regenerated silk fibroin, add it into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h to crosslink.
[0044] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0045] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0046] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0047] Example 2
[0048] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0049] Weigh 0.045 g of recombinant mussel mucin and 0.455 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.083 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h to crosslink.
[0050] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0051] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0052] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0053] Example 3
[0054] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0055] Weigh 0.11 g of recombinant mussel mucin and 1.14 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let stand at 28° C. for 48 h to crosslink.
[0056] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0057] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0058] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0059] Example 4
[0060] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0061] Weigh 0.14 g of recombinant mussel mucin and 1.11 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h for cross-linking.
[0062] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0063] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0064] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0065] Example 5
[0066] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0067] Weigh 0.21 g of recombinant mussel mucin and 1.04 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h to crosslink.
[0068] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0069] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0070] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0071] Example 6
[0072] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0073] Weigh 0.31 g of recombinant mussel mucin and 0.94 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let stand at 28° C. for 48 h to crosslink.
[0074] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0075] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0076] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0077] Example 7
[0078] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0079] Weigh 0.42 g of recombinant mussel mucin and 0.83 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h for cross-linking.
[0080] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0081] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0082] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0083] Example 8
[0084] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0085] Weigh 0.42 g of recombinant mussel mucin and 0.83 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h for cross-linking.
[0086] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0087] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0088] Weigh 20 g of microgel, add 2 g of sodium carboxymethyl cellulose solution (20 mg / ml) to the microgel, stir and compound, fill with a 1 ml prefilled syringe after compounding, and sterilize with wet heat at 121° C. for 8 min.
[0089] Example 9
[0090] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0091] Weigh 0.42 g of recombinant mussel mucin and 0.83 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h for cross-linking.
[0092] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0093] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0094] Weigh 20 g of microgel, add 2 g of polyethylene glycol-4000 solution (50 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121° C. for 8 min.
[0095] Example 10
[0096] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0097] Weigh 0.42 g of recombinant mussel mucin and 0.83 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.21 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h for cross-linking.
[0098] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0099] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0100] Weigh 20 g of microgel, add 2 g of hydroxypropyl cellulose solution (10 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121° C. for 8 min.
[0101] Embodiment 11
[0102] A method for preparing a recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue regeneration filler, the preparation method comprising the following steps:
[0103] Weigh 0.5 g of recombinant mussel mucin and 1.0 g of regenerated silk fibroin, add them into 5 ml of 12 M lithium bromide solution and stir to dissolve, then add 0.25 g of BDDE and stir evenly, and let it stand at 28° C. for 48 h for cross-linking.
[0104] The cross-linked gel was crushed into small pieces, and then washed with 150 ml of 10 mM PBS solution 10 times, 30 min each time, to remove the residual catalyst and cross-linking agent in the gel;
[0105] The washed gel was collected by filtration and passed through a 60-mesh stainless steel sieve three times to obtain microgel.
[0106] Weigh 20 g of microgel, add 2 g of sodium hyaluronate solution (4 mg / ml) to the microgel and stir to compound. After compounding, fill with a 1 ml prefilled syringe and sterilize with wet heat at 121°C for 8 min.
[0107] Figure 2 The infrared spectrum of the recombinant mussel mucin-regenerated silk fibroin composite microgel prepared in Example 7 is shown. From the figure, it can be seen that, compared with the regenerated silk fibroin microgel without adding recombinant mussel mucin (Example 1), the infrared vibration peak of dopamine phenylhydroxyl group appears in the infrared spectrum of the composite microgel with added recombinant mussel mucin, indicating that the recombinant mussel mucin and the regenerated silk fibroin are co-crosslinked to form a composite gel structure.
[0108] Figure 3 The microscope image and particle size distribution diagram of the recombinant mussel mucin-regenerated silk fibroin composite microgel prepared in Example 7 are shown. From the figure, it can be seen that the D(50) of the microgel is 665 μm and the D(90) is 1276 μm.
[0109] Figure 4 The scanning electron microscope image of the recombinant mussel mucin-regenerated silk fibroin composite microgel prepared in Example 7 after freeze-drying is shown. It can be seen from the image that the microgel has a porous network structure with a pore size of about 20-40 μm.
[0110] Figure 5A picture of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 is shown. From the picture, it can be seen that, compared with the microgel filler (Example 1) without the addition of recombinant mussel mucin, the filler with the addition of recombinant mussel mucin exhibits the yellowish-brown color unique to mussel mucin, further indicating that the recombinant mussel mucin and the regenerated silk fibroin are co-cross-linked to form a composite gel.
[0111] Figure 6 The pushing force data of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 are shown. From the figure, it can be seen that the average pushing force of the filler is 12.96N, the maximum pushing force is 25.28N, and the minimum pushing force is 8.83N. The pushing force value of the filler meets the national standard for composite soft tissue fillers.
[0112] Test Example 1
[0113] The hydrogel was incubated with 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH) solution. After 30 minutes of reaction, the OD value of the mixed solution was detected at 520 nm, and the free radical scavenging rate was calculated.
[0114] Figure 7 The antioxidant data of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Examples 1-7 are shown. It can be seen from the figure that the filler (SF / MAP-7) prepared in Example 7 can effectively reduce the concentration of reactive oxygen in cells and has the best antioxidant capacity.
[0115] Test Example 2
[0116] Fibroblasts were plated in 96-well cell culture plates and cell culture dishes, with approximately 4,000 cells per well. After 24 hours, the cells were completely attached to the wall and incubated with different hydrogel extracts. After 24 hours, CCK-8 detection reagent was added to the 96-well plate, and the cell absorbance was detected by an ELISA instrument to calculate the cell survival rate. At the same time, the cells in the cell culture dish were stained with a live / dead cell kit to detect cell viability.
[0117] Figure 8 The cytotoxicity data of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue fillers prepared in Examples 7-10 are shown. It can be seen from the figure that compared with other groups, the injectable filler (SF / MAP-7) prepared in Example 7 exhibits the best in vitro cell compatibility.
[0118] Test Example 3
[0119] The adherent macrophages were treated with lipopolysaccharide (LPS) at a concentration of 2 μg / mL, and the polarized cells were treated with different hydrogel solutions 48 hours later. After another 48 hours of incubation, the RNA expression of inflammatory factors in macrophages was detected using an RNA extraction kit and a real-time fluorescence quantitative polymerase chain reaction kit.
[0120] Fig. 9 The data of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 inducing anti-inflammatory polarization of macrophages are shown. It can be seen from the figure that the filler can effectively induce the M2 anti-inflammatory phenotype of macrophages, indicating that the filler has excellent anti-inflammatory effect.
[0121] Test Example 4
[0122] The hydrogel prepared in Example 7 was implanted into the subcutaneous position of rats. Three months later, the rats were killed, and the skin tissue implanted with the hydrogel was removed. After fixation, hematoxylin-eosin (H&E), Masson trichrome, and immunofluorescence (IF) staining were performed. At the same time, the heart, liver, spleen, lung, and kidney of the rats were removed and H&E staining was performed.
[0123] Fig.10 The extracted tissue picture of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 was implanted into the subcutaneous tissue of rats for 3 months. It can be seen from the figure that the implant was not completely degraded 3 months after implantation.
[0124] Fig.11 The H&E staining picture of the extracted tissue section 3 months after the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 was implanted subcutaneously in rats is shown. From the picture, it can be seen that only a small amount of inflammatory cells exist around the implant, indicating that the implant has good biocompatibility and will not cause serious local tissue inflammation.
[0125] Fig.12 The Masson staining picture of the extracted tissue section of the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 was implanted into the subcutaneous tissue of rats for 3 months. From the picture, it can be seen that a large number of collagen fibers are newly formed in the tissue surrounding the implant.
[0126] Fig.13 The CD31 immunofluorescence staining image of the extracted tissue section 3 months after the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 was implanted subcutaneously in rats is shown. From the image, it can be seen that obvious CD31 vascular endothelial cell membrane protein is distributed around and inside the implant, indicating that the filler has good biocompatibility and can induce autologous vascular tissue to grow into the filler.
[0127] Fig.14 The CD90 immunofluorescence staining image of the extracted tissue section 3 months after the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 was implanted subcutaneously in rats is shown. From the image, it can be seen that there is obvious CD90 protein distributed around and inside the implant, indicating that the filler has good biocompatibility and can induce autologous fibroblasts to grow and proliferate in the filler.
[0128] Fig.15 The H&E staining images of tissue sections of the main organs (heart, liver, spleen, lung, and kidney) of the rats are shown 3 months after the recombinant mussel mucin-regenerated silk fibroin composite microgel injectable soft tissue filler prepared in Example 7 was implanted subcutaneously in the rats. It can be seen from the images that the tissue sections of the main organs are normal, indicating that the filler did not cause adverse effects on the main organs of the rats 3 months after being implanted subcutaneously in the rats, further proving the good biosafety of the filler.
Claims
1. A recombinant mussel mucin-regenerated silk fibroin composite gel, comprising recombinant mussel mucin, regenerated silk fibroin and auxiliary materials, wherein the mass ratio of the cross-linking of the recombinant mussel mucin and the regenerated silk fibroin is 1:1.5-11; the auxiliary materials are selected from sodium carboxymethyl cellulose, polyethylene glycol, hydroxypropyl cellulose or sodium hyaluronate.
2. The recombinant mussel viscoprotein-regenerated silk fibroin composite gel according to claim 1, characterized in that: The recombinant mussel mucin-regenerated silk fibroin composite gel comprises recombinant mussel mucin, regenerated silk fibroin and sodium hyaluronate, wherein the cross-linking mass ratio of the recombinant mussel mucin and the regenerated silk fibroin is 42:
83.
3. The method for preparing the recombinant mussel mucin-regenerated silk fibroin composite gel according to claim 1, comprising the following steps: 1) Weigh the recombinant mussel mucin and regenerated silk fibroin, add them into lithium bromide solution and stir to dissolve, then add BDDE and stir evenly, and let stand for cross-linking; 2) The cross-linked gel was crushed into small pieces, and then the gel was washed with PBS solution to remove the catalyst and cross-linking agent remaining in the gel; 3) filtering and collecting the washed gel, and passing the gel through a stainless steel mesh to obtain microgel; 4) Weigh the microgel obtained in step 3, add the auxiliary material solution to the microgel, stir and compound, and after compounding, fill with a prefilled syringe and perform moist heat sterilization.
4. The preparation method according to claim 3, characterized in that: In the step 1), the total amount of recombinant mussel mucin and regenerated silk fibroin is 5.95 times the amount of BDDE added.
5. The preparation method according to claim 3, characterized in that: In the step 1), the amount of lithium bromide solution added is 5 ml, and the concentration is 12M.
6. The preparation method according to claim 3, characterized in that: In the step 1), the cross-linking temperature is 28° C. and the cross-linking time is 48 h.
7. The preparation method according to claim 3, characterized in that: In the step 2), the washing condition is to use 150 ml of 10 mM PBS solution to wash the gel 10 times, each time for 30 minutes.
8. The preparation method according to claim 3, characterized in that: In the step 3), the condition for obtaining the microgel is to pass the gel through a 60-mesh stainless steel sieve three times to obtain the microgel.
9. The preparation method according to claim 3, characterized in that: In the step 4), the concentration of the excipient solution is 4-50 mg / mL; in the step 4), the ratio of the excipient solution to the microgel is 1:3-1:20; in the step 4), the moist heat sterilization temperature is 121° C.; and the sterilization time is 8 min.
10. Use of the recombinant mussel mucin-regenerated silk fibroin composite gel according to claim 1 in soft tissue filling for facial plastic surgery, chronic wound repair, osteoarthritis treatment, articular cartilage defect repair, tendon injury repair, myocardial injury repair, spinal cord injury repair or brain tissue injury repair.
